Voyager Therapeutics, Inc. (VYGR) Insider Trading Disclosures
Voyager Therapeutics, Inc. (VYGR) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: VYGR
CIK: 1640266
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerMichael Mc Collister
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001172661-26-003626 | View SEC Doc Filr Page |
| 8-K | 2026-08-06 | 2026-08-06 | 8-K | 0001640266-26-000007 | View SEC Doc Filr Page |
| 10-Q | 2026-08-06 | 2026-06-30 | 10-Q | 0001640266-26-000006 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-31 | — | SCHEDULE 13G/A Filing | 0001104659-26-089311 | View SEC Doc Filr Page |
| 8-K | 2026-07-13 | 2026-07-13 | FORM 8-K | 0001104659-26-082906 | View SEC Doc Filr Page |
| 4 | 2026-06-11 | 2026-06-09 | OWNERSHIP DOCUMENT | 0001104659-26-072934 | View SEC Doc Filr Page |
| 4 | 2026-06-11 | 2026-06-09 | OWNERSHIP DOCUMENT | 0001104659-26-072927 | View SEC Doc Filr Page |
| 4 | 2026-06-11 | 2026-06-09 | OWNERSHIP DOCUMENT | 0001104659-26-072926 | View SEC Doc Filr Page |
| 4 | 2026-06-11 | 2026-06-09 | OWNERSHIP DOCUMENT | 0001104659-26-072924 | View SEC Doc Filr Page |
| 4 | 2026-06-11 | 2026-06-09 | OWNERSHIP DOCUMENT | 0001104659-26-072923 | View SEC Doc Filr Page |
| 4 | 2026-06-11 | 2026-06-09 | OWNERSHIP DOCUMENT | 0001104659-26-072922 | View SEC Doc Filr Page |
| 4 | 2026-06-11 | 2026-06-09 | OWNERSHIP DOCUMENT | 0001104659-26-072921 | View SEC Doc Filr Page |
| 4 | 2026-06-11 | 2026-06-09 | OWNERSHIP DOCUMENT | 0001104659-26-072919 | View SEC Doc Filr Page |
| 4 | 2026-06-11 | 2026-06-09 | OWNERSHIP DOCUMENT | 0001104659-26-072917 | View SEC Doc Filr Page |
| 8-K | 2026-06-10 | 2026-06-09 | FORM 8-K | 0001104659-26-072324 | View SEC Doc Filr Page |
| 8-K | 2026-06-01 | 2026-06-01 | FORM 8-K | 0001104659-26-068591 | View SEC Doc Filr Page |
| 3 | 2026-05-18 | 2026-05-08 | OWNERSHIP DOCUMENT | 0001104659-26-063176 | View SEC Doc Filr Page |
| 144 | 2026-05-15 | — | 144 Filing | 0001959173-26-003666 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0000935836-26-000263 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0001172661-26-002122 | View SEC Doc Filr Page |
| 144 | 2026-05-15 | — | 144 Filing | 0001959173-26-003638 | View SEC Doc Filr Page |
| 8-K | 2026-05-07 | 2026-05-07 | 8-K | 0001104659-26-057115 | View SEC Doc Filr Page |
| 10-Q | 2026-05-07 | 2026-03-31 | 10-Q | 0001104659-26-057097 | View SEC Doc Filr Page |
| ARS | 2026-04-28 | 2025-12-31 | ARS | 0001104659-26-050335 | View SEC Doc Filr Page |
| DEFA14A | 2026-04-28 | — | DEFA14A | 0001104659-26-050311 | View SEC Doc Filr Page |